CMS Releases 2027 OPPS Proposed Rule: Key Changes for Hospitals, Health Systems and Healthcare Providers

The Centers for Medicare and Medicaid Services (CMS) has released its proposed rule for the 2027 Outpatient Prospective Payment System (OPPS). This rule details planned changes to payment rates, policies, and quality programs that will affect hospitals, health systems, and other healthcare providers. The proposed rule aims to update how Medicare pays for outpatient services and implements several policy shifts.

Key Takeaways

• CMS proposes updating OPPS payment rates for 2027 with specific adjustments for inflation and other factors.
• The rule includes changes to the hospital outpatient quality reporting program and the outpatient quality star ratings.
• New policies address hospital price transparency requirements and the 340B drug discount program.
• Several provisions aim to streamline payment for innovative technologies and services.

What OPPS Is and Why This Rule Comes Out Every Year

The Outpatient Prospective Payment System is the framework Medicare uses to pay hospitals for services delivered in the outpatient setting, meaning care that does not require an overnight admission: same-day surgery, imaging, infusions, emergency department visits, and clinic services. Instead of paying an itemized charge for every line, OPPS groups clinically similar services that use comparable resources into Ambulatory Payment Classifications, or APCs, and pays a set rate for each. Many minor items, supplies, and ancillary services are packaged into the primary service payment rather than billed separately, which pushes hospitals to manage the total cost of an episode.

Each service carries a status indicator that tells the system how it is paid, whether it is packaged, paid separately, or excluded. A single national conversion factor scales the relative weight of each APC into an actual dollar amount, and a wage index then adjusts that amount up or down for local labor costs, so the same procedure pays differently in a high-cost metro than in a rural county. CMS is required to revisit these components every year, which is why an OPPS proposed rule lands on a predictable annual calendar. The proposed version opens a public comment window; the final rule, published later in the year, sets the rates that take effect the following January 1.

Payment Rate Updates and Adjustments

The 2027 OPPS proposed rule includes updates to standard payment rates for hospital outpatient services. According to the original report from Buchanan Ingersoll & Rooney PC, CMS projects that total payments to OPPS providers will increase by a certain percentage compared to the current year, driven largely by the market basket update and other statutory adjustments. The rule also outlines changes to the patient copayment amounts for outpatient services under Part B.

CMS proposes to continue using its standard methodology for calculating payment rates under OPPS. This includes applying budget neutrality adjustments and accounting for expected changes in utilization and case mix. The rule also addresses outlier payments for high-cost services and the supervision requirements for outpatient therapeutic services.

The Market Basket Update and Productivity Adjustment

The headline payment change each year starts with the hospital market basket, an inflation measure of the goods and services hospitals buy, from labor to supplies. From that gross update, statute requires CMS to subtract a productivity adjustment, so the net increase hospitals actually receive is smaller than raw inflation. This is why hospital associations often argue the annual update fails to keep pace with real cost growth, particularly in years when wages and drug prices rise quickly. The proposed rule projects a net increase in total OPPS payments, but the figure is an aggregate: it does not guarantee that any individual hospital comes out ahead once its own service mix and wage index are applied.

Budget Neutrality and the Wage Index

Many OPPS changes must be budget neutral, meaning that if CMS raises payment for one group of services it has to offset that elsewhere so total spending does not balloon beyond the statutory update. Reweighting APCs, changing packaging rules, or adjusting the wage index therefore creates winners and losers even in a year with an overall increase. The wage index in particular is contentious, because it redistributes money geographically and small methodology changes can move meaningful dollars between urban and rural facilities.

Site-Neutral Payment Pressure

A recurring theme in OPPS rulemaking is site-neutral payment, the policy question of whether Medicare should pay the same for a service regardless of whether it is delivered in a hospital outpatient department or a lower-cost physician office or off-campus clinic. Historically, hospital outpatient departments have been paid more for the same service, which critics say inflates costs and encourages hospitals to acquire independent practices. Provisions that move certain off-campus, provider-based department services toward physician-fee-schedule-equivalent rates are among the most financially consequential parts of any OPPS rule for large health systems.

Quality Reporting Program Changes

The proposed rule introduces updates to the Hospital Outpatient Quality Reporting (OQR) program. CMS plans to remove some existing quality measures and add new ones that align with current clinical priorities. The agency also proposes to modify how it calculates and displays outpatient quality star ratings on the Hospital Compare website. These changes aim to provide clearer information to patients while reducing administrative burden on hospitals.

CMS is seeking public comment on several aspects of the OQR program, including the timeline for adopting electronic clinical quality measures. The rule also outlines requirements for data validation and the consequences for hospitals that fail to meet reporting deadlines.

It helps to understand what the OQR program actually is. It is a pay-for-reporting program, not pay-for-performance. Hospitals are not penalized for their scores; they are penalized for failing to report. A hospital that does not meet OQR reporting requirements typically faces a reduction in its annual OPPS payment update, which is a strong financial incentive to comply even for facilities that dislike the administrative load. The measures themselves span areas like imaging efficiency, emergency department throughput, safe surgery practices, and increasingly patient-reported outcomes.

The proposed move toward electronic clinical quality measures, or eCQMs, reflects a longer-term shift away from manual chart abstraction toward data pulled directly from electronic health records. That promises less manual burden eventually, but the transition itself requires hospitals to invest in reporting infrastructure and validate that their systems produce accurate measures. The comment period is where hospitals push back on timelines they consider too aggressive.

Price Transparency and Consumer Information

Building on previous efforts to improve price transparency, the 2027 OPPS proposed rule includes new requirements for how hospitals display their charges and negotiated rates. CMS proposes to update the machine readable file format standards and require more detailed information about services and payer specific negotiated rates. Noncompliance penalties would also be adjusted under the new rule.

The proposed rule also addresses how hospitals must make their standard charges public. CMS emphasizes the importance of providing accurate and up to date pricing data to help patients make informed decisions about their care.

Hospital price transparency has been federally required since the rule that took effect on January 1, 2021. It obligates hospitals to publish a machine-readable file of all standard charges, including gross charges, discounted cash prices, and payer-specific negotiated rates, plus a consumer-friendly display of common shoppable services. Compliance has been uneven, and CMS has steadily tightened the technical standards and enforcement over successive rules. Each OPPS cycle has become a vehicle for sharpening the file format and closing loopholes that let some hospitals post data that was technically present but practically unusable.

The proposed penalty adjustments matter because early enforcement was widely seen as too light to change behavior. Standardizing the data schema is arguably as important as the penalties: when every hospital reports in the same format, third parties can aggregate and compare prices, which is the entire point of the policy. For revenue-cycle and compliance teams, transparency requirements are now a permanent operational obligation rather than a one-time project.

340B Drug Discount Program Implications

The 2027 OPPS proposed rule continues ongoing policy discussions regarding the 340B Drug Pricing Program. CMS outlines how it will handle payments for drugs acquired under the 340B program, including potential rate adjustments. The agency also addresses the question of whether certain 340B acquired drugs should be paid at lower rates compared to non 340B drugs. The rule seeks comments on how best to ensure the program remains financially neutral for both hospitals and the Medicare program.

The 340B program lets certain safety-net hospitals and clinics buy outpatient drugs at steep discounts, with the savings intended to stretch scarce resources for underserved patients. The tension is that Medicare historically reimbursed hospitals close to a drug’s average sales price even though the hospital acquired it far below that, creating a spread. From 2018, CMS cut reimbursement for 340B-acquired drugs to roughly 22.5% below the average sales price, a policy hospitals fought hard.

In 2022 the U.S. Supreme Court ruled unanimously that CMS had not followed the required process to impose those cuts, and CMS subsequently had to unwind the reduced rates and address remedy payments for the affected years. That history is why 340B language in any OPPS rule now draws intense scrutiny. Hospitals want assurance that payment for 340B drugs is stable and that any adjustment is done through a legally defensible process, while CMS aims to keep the program budget neutral for Medicare. For disproportionate-share and rural referral hospitals, 340B economics can be the difference between a viable outpatient pharmacy program and a shuttered one.

Innovation and Technology Policies

CMS proposes several changes to encourage the adoption of innovative medical technologies in the outpatient setting. The rule includes pathways for new devices and diagnostics to receive special payment designation, which can help speed patient access to cutting edge treatments. The agency also provides updates to its current list of covered outpatient drugs and biological products, including new drug administration codes and payment adjustments.

The proposed rule addresses how Medicare will pay for certain cell and gene therapies, as well as digital health products, when services are provided in hospital outpatient departments. CMS is also seeking feedback on mechanisms to support value based payment arrangements related to outpatient care.

The mechanics behind these innovation provisions are worth knowing. Transitional pass-through payments give new drugs, biologicals, and devices temporary separate payment on top of the standard APC rate, so a genuinely new technology is not buried inside a packaged rate that predates it. New-technology APCs provide a home for services that do not yet have enough cost data to be classified normally. CMS also updates the Inpatient Only list, which names procedures Medicare will only pay for in the inpatient setting, and the list of procedures approved for ambulatory surgical centers. Moving a procedure off the Inpatient Only list or onto the ASC-covered list can shift where care is delivered and who gets paid for it.

Who Feels These Changes, and How

An OPPS rule is often discussed as a hospital story, but its effects fan out to several groups.

• Hospitals and health systems. Payment rates, the wage index, and site-neutral provisions directly shape outpatient margins. Large systems with many off-campus departments have the most exposure to site-neutral policy.
• Rural and safety-net hospitals. These facilities are the most sensitive to 340B economics and to wage-index redistribution, and they often operate on the thinnest margins, so a small rate change can be consequential.
• Ambulatory surgical centers. Additions to the ASC-covered procedures list expand what these lower-cost sites can do, which affects both patient access and competition with hospital outpatient departments.
• Patients. Part B copayment amounts are tied to OPPS rates, so payment changes flow through to what beneficiaries owe out of pocket. Price transparency provisions are aimed squarely at helping patients compare costs before care.
• Device and drug makers. Pass-through payment and new-technology pathways determine how quickly a new product reaches patients in the outpatient setting.

How to Read and Respond to a Proposed Rule

A proposed rule is exactly that, a proposal. It is not yet law, and provisions can change substantially between the proposed and final versions based on the comments CMS receives. That distinction matters: hospitals should plan for the range of likely outcomes rather than treat the proposal as settled. CMS opens a public comment period, typically running about 60 days, and anyone, from a large hospital association to an individual clinician, can submit a comment through the federal rulemaking portal at regulations.gov.

Effective comments are specific. They cite the exact provision, explain the real-world operational or financial impact with concrete examples, and where possible propose an alternative. CMS is legally required to consider substantive comments and respond to them in the final rule, which is why organized, well-evidenced feedback genuinely shapes the outcome. For a hospital finance or compliance team, the practical workflow is to model the proposed rates against the facility’s own case mix, flag the provisions with the largest impact, and either comment directly or feed input to a hospital association that will.

The Bigger Shift: More Cost and Choice Land on the Patient

Step back from the regulatory detail and a pattern emerges across payment, transparency, and site-neutral policy: patients are being handed more visibility into prices and, increasingly, more of the cost. As that happens, more people are choosing to be proactive about their own health data and access to a clinician rather than waiting inside a system in flux. For readers thinking along those lines, two direct-to-consumer options come up often.

Both are out-of-pocket services and neither replaces Medicare coverage, a hospital, or a primary care relationship. They are simply tools some readers use to get a complete picture of their numbers and a clinician’s review without navigating the institutional system first.

Frequently Asked Questions

What is the timeline for the 2027 OPPS proposed rule?

The proposed rule was released by CMS and is subject to a public comment period. Following review of comments, CMS will publish a final rule later this year. The final policy changes will take effect on January 1, 2027, for hospital outpatient services.

How will the 2027 OPPS proposed rule affect hospital reimbursement?

The rule includes an update to the base payment rate for outpatient services, which will increase total Medicare payments to OPPS providers, according to the original report. However, individual hospitals may see different impacts depending on their service mix, case complexity, and compliance with quality reporting programs. Changes to the 340B program and price transparency requirements could also affect overall reimbursement levels for some facilities.

What should hospitals do now to prepare for the 2027 OPPS changes?

Hospitals should review the proposed rule carefully and consider submitting comments to CMS before the deadline. The original report recommends that healthcare providers assess how the proposed payment changes, quality measure updates, and transparency mandates will affect their operations. Hospitals may also need to update their compliance procedures and billing systems to align with the anticipated new requirements.

What is an APC in the OPPS system?

An Ambulatory Payment Classification is a group of clinically similar outpatient services that use comparable resources and are paid at a single rate. Grouping services into APCs, and packaging many minor items into the primary payment, is the core mechanism that makes OPPS a prospective payment system rather than a fee-for-each-item system.

What is the difference between a proposed rule and a final rule?

A proposed rule is CMS’s draft policy, published to gather public comment, and it can change before it takes effect. A final rule reflects CMS’s decisions after reviewing those comments and is the version that becomes binding. For the 2027 OPPS rule, the final policies are expected to take effect on January 1, 2027.

What is site-neutral payment?

Site-neutral payment is the policy of paying the same amount for a given service regardless of whether it is delivered in a hospital outpatient department or a lower-cost setting like a physician office. Because hospital outpatient departments have historically been paid more, site-neutral provisions can significantly reduce revenue for health systems with many off-campus clinics.

Why does the 340B program matter in this rule?

340B lets qualifying safety-net hospitals buy outpatient drugs at deep discounts. How Medicare reimburses those drugs affects the savings hospitals can use for underserved patients. After the Supreme Court rejected an earlier payment cut in 2022, any 340B change in an OPPS rule is watched closely for both its financial impact and whether it follows proper process.

This is an original report by Vital Signs Today, informed by reporting from Google News. Read the original source.

This article is for information only and is not medical advice. See our Medical Disclaimer.